Tumor Biology for the Clinician

Marsh P.J. , James R.D. , Schofield P.F. . Adjuvant preoperative radiotherapy for locally advanced carcinoma: results of a prospective, randomized trial. Dis Colon Rectum. 1994; 37: 1205–1214.

Holm T. , Cedermark B. , Rutqvist L.E. . Local recurrence of rectal adenocarcinoma after “curative” surgery with and without preoperative radiotherapy. Br J Surg. 1994; 81: 452–455.

Lingareddy V. , Mohiuddin M. , Marks G. . The importance of patient selection for adjunctive postoperative radiation therapy for cancer of the rectum: a patient selection in adjunctive therapy. Cancer. 1994; 73: 1805–1810.

Altman K.I. , Gerber G.B. , Okada S. . Radiation Biochemistry. Vol 1. Academic Press: New York, NY; 1970: 247.

Iliakis G. . Cell cycle regulation in irradiated and nonirradiated cells. Semin Oncol. 1997; 24: 602–615.

Little J.B. . Delayed initiation of DNA synthesis in irradiated human diploid cells. Nature. 1968; 218: 1064–1065.

Levine A.J. . p53, the cellular gatekeeper for growth and division. Cell. 1997; 88: 323–331.

Dulic V. , Kaufmann W.K. , Wilson S.J. . p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G₁ arrest. Cell. 1994; 76: 1013–1023.

el-Deiry W.S. , Tokino T. , Velculescu V.E. . WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75: 817–825.

Lu X. , Lane D.P. . Differential induction of transcriptionally active p53 following UV or ionizing irradiation: defects in chromosome instability syndromes? Cell. 1993; 75: 765–778.

Wagner A.J. , Kokontis J.M. , Hay N. . Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 1994; 8: 2817–2830.

Elledge S.J. . Cell cycle checkpoints: preventing an identity crisis. Science. 1996; 274: 1664–1672.

Kastan M.B. , Zhan Q. , el-Deiry W.S. . A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 1992; 71: 587–597.

Momand J. , Zambetti G.P. , Olson D.C. . The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell. 1992; 69: 1237–1245.

Ko L.J. , Prives C. . p53: puzzle and paradigm. Genes Dev. 1996; 10: 1054–1072.

Watanabe I. . Radiation effects on DNA chain growth in mammalian cells. Radiat Res. 1974; 54: 541–556.

Povirk L.F. . Localization of inhibition of replicon initiation to damaged regions of DNA. J Mol Biol. 1977; 114: 141–151.

Lamb J.R. , Petit-Frere C. , Broughton B.C. . Inhibition of DNA replication by ionizing radiation is mediated by a trans-acting factor. Int J Radiat Biol. 1989; 56: 125–130.

Painter R.B. , Young B.R. . Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci U S A. 1980; 77: 7315–7317.

Nakamura Y. . ATM: the p53 booster. Nat Med. 1998; 4: 1231–1232.

Wang Y. , Iliakis G. . Prolonged inhibition by x-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc. Cancer Res. 1992; 52: 508–514.

Wang Y. , Cheong N. , Miura M. . Overexpression of insulin-like growth factor (IGF)-1 receptor enhances inhibition of DNA replication in mouse cells exposed to x-rays. Radiat Environ Biophys. 1997; 36: 117–123.

Larner J.M. , Lee H. , Hamlin J.L. . Radiation effects on DNA synthesis in a defined chromosomal replicon. Mol Cell Biol. 1994; 14: 1901–1908.

Tobey R.A. . Different drugs arrest cells at a number of distinct stages in G₂. Nature. 1975; 254: 245–247.

Kao G.D. , McKenna W.G. , Maity A. . Cyclin B1 availability is a rate-limiting component of the radiation-induced G₂ delay in HeLa cells. Cancer Res. 1997; 57: 753–758.

Metting N.F. , Little J.B. . Transient failure to dephosphorylate the cdc2-cyclin B1 complex accompanies radiation-induced G₂-phase arrest in HeLa cells. Radiat Res. 1995; 143: 286–292.

O'Connor P.M. , Ferris D.K. , Hoffmann I. . Role of the cdc25C phosphatase in G₂ arrest induced by nitrogen mustard. Proc Natl Acad Sci U S A. 1994; 91: 9480–9484.

Thompson C.B. . Apoptosis in the pathogenesis and treatment of disease. Science. 1995; 276: 1456–1462.

Nagata S. , Golstein P. . The Fas death factor. Science. 1995; 267: 1449–1456.

Yin C. , Knudson C.M. , Korsmeyer S.J. . Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature. 1997; 385: 637–640.

Prisco M. , Hongo A. , Rizzo M.G. . The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol Cell Biol. 1997; 17: 1084–1092.

Buckbinder L. , Talbott R. , Velasco-Miguel S. . Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature. 1995; 377: 646–649.

Bian J. , Sun Y. . Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol. 1997; 17: 6330–6338.

Sabbatini P. , Chiou S.K. , Rao L. . Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol Cell Biol. 1995; 15: 1060–1070.

Tan X. , Martin S.J. , Green D.R. . Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J Biol Chem. 1997; 272: 9613–9616.

Sheard M.A. , Vojtesek B. , Janakova L. . Up-regulation of Fas (CD95) in human p53 wild type cancer cells treated with ionizing radiation. Int J Cancer. 1997; 73: 757–762.

Harrington E.A. , Fanidi A. , Evan G.I. . Oncogenes and cell death. Curr Opin Genet Dev. 1994; 4: 120–129.

O'Reilly L.A. , Harris A.W. , Tarlinton D.M. . Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo. J Immunol. 1997; 159: 2301–2311.

Brady H.J. , Gil-Gomez G. , Kirberg J. . Bax alpha perturbs T cell development and affects cell cycle entry of T cells. EMBO J. 1996; 15: 6991–7001.

Ashkenazi A. , Dixit V.M. . Death receptors: signaling and modulation. Science. 1998; 281: 1305–1308.

Raybaud-Diogene H. , Fortin A. , Morency R. . Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. J Clin Oncol. 1997; 15: 1030–1038.

Desai G.R. , Myerson R.J. , Higashikubo R. . Carcinoma of the rectum: possible cellular predictors of metastatic potential and response to radiation therapy. Dis Colon Rectum. 1996; 39: 1090–1096.

Servomaa K. , Kiuru A. , Grenman R. . p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines. Cell Prolif. 1996; 29: 219–230.

McIlwrath A.J. , Vasey P.A. , Ross G.M. . Cell cycle arrest and radiosensitivity of human tumor cell lines: dependence on wild type p53 for radiosensitivity. Cancer Res. 1994; 54: 3718–3722.

Hamada M. , Fujiwara T. , Hizuta A. . The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers. J Cancer Res Clin Oncol. 1996; 122: 360–365.

Brachman D.G. , Beckett M. , Graves D. . p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res. 1993; 53: 3667–3669.

Zellars R.C. , Naida J.D. , Davis M.A. . Effect of p53 overexpression on radiation sensitivity of human colon cancer cells. Radiat Oncol Invest. 1997; 5: 43–49

Fu C.G. , Tominaga O. , Nagawa H. . Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients. Dis Colon Rectum. 1998; 41: 68–74.

O'Rourke D.M. , Kao G.D. , Singh N. . Conversion of a radioresistant phenotype to a more sensitive one by disabling erbB receptor signaling in human cancer cells. Proc Natl Acad Sci U S A. 1998; 95: 10842–10847.

Balaban N. , Moni J. , Shannon M. . The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation. Biochim Biophys Acta. 1996; 1314: 147–156.

Yao S.L. , Akhtar A.J. , McKenna K.A. . Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nat Med. 1996; 2: 1140–1143.

Bowen C. , Spiegel S. , Gelmann E.P. . Radiation-induced apoptosis mediated by retinoblastoma protein. Cancer Res. 1998; 58: 3275–3281.

Sakakura C. , Sweeney E.A. , Shirahama T. . Overexpression of bax enhances the radiation sensitivity in human breast cancer cells. Surg Today. 1997; 27: 90–93.

Bristow R.G. , Benchimol S. , Hill R.P. . The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol. 1996; 40: 197–223.

Spitz F.R. , Nguyen D. , Skibber J.M. . Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Clin Cancer Res. 1996; 2: 1665–1671.

Gallardo D. , Drazan K.E. , McBride W.H. . Adenovirus-based transfer of wild type p53 gene increases ovarian tumor radiosensitivity. Cancer Res. 1996; 56: 4891–4893.